Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colorectal Cancer, Ovarian Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT06546553
What this trial is testing

Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.

Who this might be right for
NeoplasmsNon-small-cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+3 more
Pfizer 10
Testing effectiveness (Phase 2)Study completedNCT00004895
What this trial is testing

Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery

Who this might be right for
Colorectal CancerConstipation, Impaction, and Bowel ObstructionExtrahepatic Bile Duct Cancer+7 more
Northwestern University
Not applicableStudy completedNCT04726319
What this trial is testing

Family History App in Personalized Medicine

Who this might be right for
Cancer, BreastCancer, OvarianCancer, Colorectal+4 more
University of Toronto 627
Not applicableNot Yet RecruitingNCT07814872
What this trial is testing

A Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment

Who this might be right for
Neoplasms (Cancer / Tumors)Colorectal NeoplasmsLung Neoplasms+8 more
Harvard Medical School (HMS and HSDM) 30,000
Early research (Phase 1)UnknownNCT05311618
What this trial is testing

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerBreast CancerGastric Cancer+13 more
NGM Biopharmaceuticals, Inc 71
Not applicableLooking for participantsNCT07782164
What this trial is testing

Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study)

Who this might be right for
Colorectal CarcinomaRenal CancerBladder Cancer+6 more
Amsterdam UMC, location VUmc 27
Early research (Phase 1)Study completedNCT00073944
What this trial is testing

BCX-1777 in Treating Patients With Refractory Cancer

Who this might be right for
Cancer
BioCryst Pharmaceuticals
Very early researchNot Yet RecruitingNCT07781852
What this trial is testing

Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer

Who this might be right for
Bladder CancerGliomaGlioblastoma (GBM)+13 more
Lumina Pharmaceuticals Inc 40
Not applicableUnknownNCT04279509
What this trial is testing

Selecting Chemotherapy With High-throughput Drug Screen Assay Using Patient Derived Organoids in Patients With Refractory Solid Tumours (SCORE)

Who this might be right for
OrganoidsHNSCCEpithelial Ovarian Cancer+1 more
National University Hospital, Singapore 35
Not applicableLooking for participantsNCT05142033
What this trial is testing

Avera Cancer Sequencing and Analytics Protocol (ASAP)

Who this might be right for
CancerCancer DiagnosisEarly Detection of Cancer+9 more
Avera McKennan Hospital & University Health Center 25,000
Early research (Phase 1)Looking for participantsNCT06910657
What this trial is testing

IDOV-Immune for Advanced Solid Tumors

Who this might be right for
Colorectal CancerPancreatic CancerMelanoma+13 more
ViroMissile, Inc. 78
Very early researchActive Not RecruitingNCT04147494
What this trial is testing

Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues

Who this might be right for
Breast CarcinomaColon CarcinomaEsophageal Carcinoma+8 more
Jonsson Comprehensive Cancer Center 29
Early research (Phase 1)Looking for participantsNCT05005403
What this trial is testing

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Who this might be right for
Non-Small Cell Lung CancerHead and Neck Squamous Cell CarcinomaMicro Satellite Stable Colorectal Cancer+4 more
AbbVie
Early research (Phase 1)Study completedNCT03199586
What this trial is testing

Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies

Who this might be right for
Breast CancerPancreas CancerProstate Cancer+6 more
Novita Pharmaceuticals, Inc. 23
Early research (Phase 1)Study completedNCT00513851
What this trial is testing

Phase 1 Study of OSI-930 in Cancer Patients

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Inc 60
Not applicableNot Yet RecruitingNCT07160010
What this trial is testing

Clinical Validation of Sophia Genetics Assay

Who this might be right for
Ovarian CancerBreast CancerLynch Syndrome+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 248
Not applicableAvailableNCT06751524
What this trial is testing

Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval

Who this might be right for
Colorectal Cancer (CRC)Pancreatic CancerNon-Small Cell Lung Cancer (NSCLC)+5 more
Agenus Inc.
Early research (Phase 1)Active Not RecruitingNCT05215574
What this trial is testing

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerBreast CancerGastric Cancer+13 more
NGM Biopharmaceuticals, Inc 130
Not applicableStudy completedNCT05697198
What this trial is testing

PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine

Who this might be right for
Lung CancerOvarian CancerUterine Cancer+10 more
Labcorp Corporation of America Holdings, Inc 1,429
Not applicableStudy completedNCT06973161
What this trial is testing

ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors

Who this might be right for
Bladder CancerBiliary Tract CancerCervical Cancer+6 more
AstraZeneca 140
Next Page
694